Association of CSF, Plasma, and Imaging Markers of Neurodegeneration With Clinical Progression in People With Subjective Cognitive Decline.
Jarith L EbenauWiesje PelkmansInge M W VerberkSander C J VerfaillieKarlijn A van den BoschMardou van LeeuwenstijnLyduine E CollijPhilip ScheltensNiels D PrinsFrederik BarkhofBart N M van BerckelCharlotte E TeunissenWiesje Maria van der FlierPublished in: Neurology (2022)
This study provides Class II evidence that HV, NfL, and GFAP predicted clinical progression beyond A and T in individuals with SCD.